Status:
UNKNOWN
Optimal Strategy of Primary PCI for Left Main Coronary Artery Occlusion Induced AMI
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Acute Myocardial Infarction
Percutaneous Coronary Intervention
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study will compare clinical outcomes of immediate stent implantation with deferred stent implantation(4-10days after primary angiography) for patients presented with acute myocardial infarction d...
Detailed Description
Primary percutaneous coronary intervention for patients presented with acute myocardial infarction caused by left main coronary artery occlusion is associated with significantly higher mortality and r...
Eligibility Criteria
Inclusion
- Clinical diagnosis of acute myocardial infarction occured within 12 hours
- Left main coronary artery occlusion confirmed by angiography
- Left main coronary artery occlusion (TIMI flow 0,1 or 2) confirmed by primary angiography, TIMI flow grade 3 achieved after pretreatment of thrombus aspiration or balloon dilatation
Exclusion
- Life expectancy less than 1 years
- Cardiogenic shock
- Chronic kidney disease, stage 4 by KDOQI(GFR\<30ml/min)
- Contraindications to aspirin or other anti-platelet drugs
- Allergy to contrast agent, rapamycin or paclitaxel
- Patients who are included in other ongoing trials
- Pregnant female
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2022
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT03282773
Start Date
November 1 2017
End Date
July 31 2022
Last Update
November 21 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan Hospital
Shanghai, Shanghai Municipality, China, 200032